Analyst consensus rating
LeMaitre Vascular Analyst Rating: Buy
LMAT is rated Buy by 7 analysts with a $107.00 target. As of 2026-08-29.
Direct answer
LeMaitre Vascular's consensus rating is Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $107.00.
Forecast evidence checked August 29, 2026.
Get free LeMaitre Vascular email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $80.45
- Average price target
- $107.00
- High price target
- $132.00
- Low price target
- $81.00
- Low target gap
- +0.7%
- Target upside
- +33%
- High target gap
- +64.1%
- Target range width
- 63.4%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for LeMaitre Vascular?
LeMaitre Vascular has a verified Buy consensus. The same dataset has an average price target of $107.00.
How far are LeMaitre Vascular's low and high targets from the recorded price?
The low target implies +0.7%, while the high target implies +64.1%.
How many analysts are included in LeMaitre Vascular's consensus?
The verified consensus includes 7 analysts.
How is LeMaitre Vascular's target upside or downside calculated?
The average target of $107.00 is divided by the recorded price of $80.45, then one is subtracted to produce +33%. This does not guarantee a future return.
When was LeMaitre Vascular's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.